← Open Payments lookup

PETER VAN DYCK: Open Payments

NPI 1730275470 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$309 in 16 payments from 10 companies in 2025. Trend: 2023 $100 · 2024 $539 · 2025 $309

Food & beverage: $309
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$83
Axsome Therapeutics, Inc.3$46
Otsuka America Pharmaceutical, Inc.2$33
ABBVIE INC.1$29
Almatica Pharma LLC1$23
Neurocrine BioSciences, Inc.1$22
Takeda Pharmaceuticals U.S.A., Inc.1$21
Teva Pharmaceuticals USA, Inc.1$20
Neos Therapeutics, LP1$16
E.R. Squibb & Sons, L.L.C.1$16

Products named: CAPLYTA, Auvelity, REXULTI, VRAYLAR, LOREEV XR, INGREZZA, TRINTELLIX, AUSTEDO XR.

Industry payments across NC — which companies pay providers there.